1
PICO QUESTION
PICO Question
, PICO QUESTION 2
PICO Question
Type 1 diabetes is an autoimmune disease in which the pancreas produces little or no
insulin (Klandorf & Stark, 2017). Type 1 diabetes affects both children and adults and causes
dependence on insulin for life (Klandorf & Stark, 2017). While insulin can make living with
Type 1 diabetes manageable, it does not cure the disease (Klandorf & Stark, 2017). Long-term,
uncontrolled glucose levels can lead to serious side effects, which may include kidney failure,
nerve damage, eye damage, stroke and several other complications (Klandorf & Stark, 2017).
Therefore, evaluating if adults with type 1 diabetes and uncontrolled blood glucose levels does
continuous glucose monitoring technologies versus self-monitoring of blood glucose provide
better HbA1c control is a question relevant to research.
In this PICO question, the population that is being researched is type 1 diabetics with
uncontrolled blood glucose levels. The intervention is to continuously monitor blood glucose
levels versus conventional finger stick methods. The comparison would be to monitor the blood
glucose levels by a continuous glucose monitor versus conventional finger stick monitoring with
the outcome determining if the continuous monitoring lowers HbA1c levels. No time was
incorporated into the study, however, studies that are longer in duration of six months to a year
would probably yield long term results of continuous blood glucose monitors in relation to
HbA1c levels.
The diagnosis of patients with diabetes is based on circulating fasting glucose and
glycated hemoglobin (HbA1c) levels (Yamada et al., 2017, p. 10). HbA1c levels are considered
to be the gold standard in diagnosing and developing treatment plans for diabetics due to the fact
that HbA1c levels have shown to have a direct relationship with diabetic complications (Yamada
et al., 2017, p. 10). Due to the fact that HbA1c levels represent the average life of a red blood
PICO QUESTION
PICO Question
, PICO QUESTION 2
PICO Question
Type 1 diabetes is an autoimmune disease in which the pancreas produces little or no
insulin (Klandorf & Stark, 2017). Type 1 diabetes affects both children and adults and causes
dependence on insulin for life (Klandorf & Stark, 2017). While insulin can make living with
Type 1 diabetes manageable, it does not cure the disease (Klandorf & Stark, 2017). Long-term,
uncontrolled glucose levels can lead to serious side effects, which may include kidney failure,
nerve damage, eye damage, stroke and several other complications (Klandorf & Stark, 2017).
Therefore, evaluating if adults with type 1 diabetes and uncontrolled blood glucose levels does
continuous glucose monitoring technologies versus self-monitoring of blood glucose provide
better HbA1c control is a question relevant to research.
In this PICO question, the population that is being researched is type 1 diabetics with
uncontrolled blood glucose levels. The intervention is to continuously monitor blood glucose
levels versus conventional finger stick methods. The comparison would be to monitor the blood
glucose levels by a continuous glucose monitor versus conventional finger stick monitoring with
the outcome determining if the continuous monitoring lowers HbA1c levels. No time was
incorporated into the study, however, studies that are longer in duration of six months to a year
would probably yield long term results of continuous blood glucose monitors in relation to
HbA1c levels.
The diagnosis of patients with diabetes is based on circulating fasting glucose and
glycated hemoglobin (HbA1c) levels (Yamada et al., 2017, p. 10). HbA1c levels are considered
to be the gold standard in diagnosing and developing treatment plans for diabetics due to the fact
that HbA1c levels have shown to have a direct relationship with diabetic complications (Yamada
et al., 2017, p. 10). Due to the fact that HbA1c levels represent the average life of a red blood
